The outlook revision reflects the the hospital’s fiscal year 2018 performance, which was above expectation, and capped a three-year trend of improving operations.
S&P also affirmed its “BBB” long-term rating for Boston Medical Center.
More articles on healthcare finance:
For-profit hospital stock report: Week of March 4-8
5 tips from hospital CFOs
Texas physicians group opposes legislation to combat surprise ER bills
